go back

Prostate Cancer Antibody Response Score

Washington, DC rates for HCPCS 0021U

Assesses the likelihood of prostate cancer by measuring the immune system's antibody response to eight tumor-associated proteins, including ARF6, NKX3-1, BMI1, CEP164, Ropporin, desmocollin, AURKAIP-1 and CSNK2A2. The eight results are combined into a single risk score, and no genetic material is examined.

Facilitymedian $912 · 10th–90th $575$4,6770%20%40%10th90th$912Professionalmedian $575 · 10th–90th $537$7410%50%10th90th$575$500.0$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$575.44
Median
$575.44
Typical High
$4,677.35
Aetna
Setting
Professional
Modifier
Global
Typical Low
$537.03
Median
$575.44
Typical High
$741.31
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$602.56
Median
$602.56
Typical High
$602.56
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,230.27
Median
$1,288.25
Typical High
$2,884.03
Cigna
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$870.96
Typical High
$1,096.48
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$912.01
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$954.99